Pei Lin - Concepedia

Author

Pei Lin

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Chudamani, Sudha, Defreitas, Timothy, DiCara, Daniel, Dominique Plantaz, Flow, Gan Di Li, Gordon Saksena, Hoehn, Daniela, Lin Pei, Lin Pei -

386

Publications

9.7K

Citations

H-Index

111

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center

About

Pei Lin is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	92	4.4K
2	Health Sciences	14	18	832
3	Public Health	2	2	65
4	Engineering	1	1	21
5	Social Sciences	1	1	15

Pei Lin

147

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
Double hit lymphoma: the <scp>MD A</scp> nderson <scp>C</scp> ancer <scp>C</scp> enter clinical experience Yasuhiro Oki, Mansoor Noorani, Pei Lin, British Journal of Haematology	2014	361
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype Nitin Jain, Audrey Lamb, Susan O’Brien, Blood	2016	338
B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome Shaoying Li, Pei Lin, Luis Fayad, Modern Pathology Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyHematology	2011	246
Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis Anuradha Kanungo, L. Jeffrey Medeiros, Lynne V. Abruzzo, Modern Pathology Lymphoid Neoplasia8Q24/c-myc TranslocationAutoimmune DiseaseConcurrent TMedicine	2005	209
Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting Maria Arroz, Neil Came, Pei Lin, Cytometry Part B Clinical Cytometry	2015	182
Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation Zhiqiang Liu, Jingda Xu, Jin He, Oncotarget	2015	160
PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma Yuhuan Zheng, Jing Yang, Junyan Qian, Leukemia InflammationHematological MalignancyMalignant Blood DisorderImmunologyIcam-1/cd18 Interactions	2012	153
<i>Bmi-1</i> is a target gene for SALL4 in hematopoietic and leukemic cells Jianchang Yang, Li Chai, Fang Liu, Proceedings of the National Academy of Sciences GeneticsImmunologyMurine Sall4Mouse Bone MarrowTarget Gene	2007	135
Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition Maryalice Stetler‐Stevenson, Bruno Paiva, Lloyd M. Stoolman, Cytometry Part B Clinical Cytometry	2015	135
Human C-Reactive Protein Binds Activating Fcγ Receptors and Protects Myeloma Tumor Cells from Apoptosis Jing Yang, Michele Wezeman, Xiang Zhang, Cancer Cell InflammationCytokineApoptosisImmunologyCell Death	2007	125

Page 1